Short and long-term clinical outcomes
| Clinical outcomes | Early coronary intervention group (n=81) | Delayed coronary intervention group (n=81) | P value |
| At 30 days | |||
| Composite cardiovascular outcome (%) | 4 (4.9) | 2 (2.5) | 0.682 |
| Rehospitalised with ACS | 0 (0) | 0 (0) | NS |
| Rehospitalised with HF | 2 (2.5) | 1 (1.2) | 0.561 |
| Stroke | 0 (0) | 0 (0) | NS |
| Death | |||
| Cardiovascular death | 2 (2.5) | 1 (1.2) | 0.567 |
| Non-cardiovascular death | 0 (0) | 0 (0) | NS |
| Loss to follow-up (%) | 0 (0) | 0 (0) | NS |
| At 6 months | |||
| Composite cardiovascular outcome (%) | 13 (16.1) | 5 (6.2) | 0.054 |
| Rehospitalised with ACS | 2 (2.5) | 0 (0) | 0.156 |
| Rehospitalised with HF | 7 (8.6) | 2 (2.5) | 0.865 |
| Stroke | 0 (0) | 0 (0) | NS |
| Death | |||
| Cardiovascular death | 4 (4.9) | 2 (2.5) | 0.408 |
| Non-cardiovascular death | 0 (0) | 1 (1.2) | 0.320 |
| Loss to follow-up (%) | 0 (0) | 0 (0) | NS |
| 6-month LVEF (%) | 58.6±8.3 | 59.4±8.4 | 0.503 |
| Staged PCI in multivessel CAD (%) | 7 (9.5) | 3 (4.1) | 0.327 |
ACS, acute coronary syndrome;CAD, coronary artery disease; HF, heart failure;LVEF, left ventricular ejection fraction; NS, non-significant; PCI, percutaneous coronary intervention.